The interconnection is far deeper than previously thought, raising new ways to promote health, says Fernando Testai.

It’s time for an endpoint that includes quality of life and mortality, and weights events accordingly, says one surgeon.

CCCTN registry data reinforce the message that DanGer Shock’s findings supporting MCS apply narrowly to patients studied.

Surviving a SARS-CoV-2 infection may be a reason to be more vigilant about general CV prevention measures moving forward.

The experts provide a how-to on dealing with sticky situations, such as no-flow and large thrombus, during PCI for STEMI.

The novel GLP-1 receptor agonists will likely reduce the need for CABG and improve surgical outcomes, several argue.

Whether to use ATP is not clear-cut and the choice should be made through shared decision-making, one expert says.

The data shed more light on how patients in the real world are faring after CAR T-cell treatment, says Sarju Ganatra.

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...